Pharmacology of the Adrenergic Mechanism

  • A. K. Pfeifer
Conference paper
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 11)


The change of susceptibility to seizures was chosen as a model to investigate transmission mechanisms in the central nervous system. Catecholamine depletors, such as reserpine, prenylamine and guanethidine increase the susceptibility to seizures, given after administration of a monoamineoxidase inhibitor, however, they are anticonvulsive. α-Methyl-m-tyrosine and α-methyl-m-tyramine which decrease brain catecholamine levels did not influence the susceptibility to seizures, possibly these methyl analogues act as false transmitters in this respect. P-Cl-amphetamine inhibited the noradrenaline and dopamine depletion produced by α-methyl-m-tyrosine, but did not change the subcellular distribution of metaraminol. P-Clamphetamine and some other amphetamine derivatives exerted anti-convulsive effect and inhibited the reserpine induced facilitation of convulsions. The anticonvulsive effect of p-Cl-amphetamine seemed to be independent of its serotonin depleting action. Studying the interaction of amphetamine derivatives and catecholamine depletors or receptor inhibitors the results suggested, that the central nervous system excitation and the ability to decrease susceptibility to seizures caused by amphetamine and its derivatives are independent effects. The subcellular distribution of amphetamine and p-Cl-amphetamine showed that this drugs are present in a relatively high concentration in the fraction containing synaptic vesicles. It is suggested that amphetamine and some of its derivatives are able to substitute cerebral catecholamines functionally and some effects of these drugs (e. g. the anticonvulsive effect) may be direct ones.


Subcellular Distribution Adrenergic Mechanism Amphetamine Derivative Methyl Analogue Fluorescence Microscopic Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andén, N.-E.: On the mechanism of noradrenaline depletion by u-methylmetatyrosine and metaraminol. Acta pharmac. Toxicol. 21, 260–271 (1964).Google Scholar
  2. Carlsson, A., and Margit Lindqvist: In vivo decarboxylation of u-methylDOPA and a-methyl-m-Tyrosine. Acta physiol. scand. 54, 87–94 1962 ).PubMedCrossRefGoogle Scholar
  3. Cass, R., and B. A. Callingham: Some effects of drugs which influence sympathetic transmission on tissue catecholamine level in the rat. Biochem. Pharmac. 13, 1619–1625 (1964).CrossRefGoogle Scholar
  4. De Robertis, E.: Adrenergic endings and vesicles isolated from brain. Pharmac. Rev. 18, 413–424 (1966).Google Scholar
  5. Fuller, R. W., C. W. Hines, and J. Mills: Lowering of brain serotonin level by chloramphetamine. Biochem. Pharmac. 14, 483–488 (1965).CrossRefGoogle Scholar
  6. Issekutz, B., and Z. Dirner: Wirkungsort des Thyroxins. Arch. exp. Path. Pharmak. 185, 685–706 (1937).CrossRefGoogle Scholar
  7. Issekutz, B., and L. Gyermek: Die Wirkung von Dihydroergotamin und Dihydroergocornin auf den Gaswechsel. Arch. int. Pharmac. 178, 174–196 (1949).Google Scholar
  8. Miller, F. P., R. H. Cox, Jr., W. R. Snodgrass, and R. P. Maickel: Comparative effects of p-Chlorophenylamine, p-Chloroamphetamine and p-Chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxy-indole-3-acetic acid. Biochem. Pharmac. 19, 435–442 (1970).CrossRefGoogle Scholar
  9. Pfeifer, A. K., and E. Galambos: The effect of (±)-p-chloroamphetamine on the susceptibility to seizures and on the monoamine level in brain and heart of mice and rats. J. Pharm. Pharmac. 19, 400–402 (1967).CrossRefGoogle Scholar
  10. Pfeifer, A. K., I. Pataky, É. Satory, and P. Vértes: Observations on the early pharmacological effects of thyroxine. Arch. int. Pharmac. Ther. 127, 44–57 (1960).Google Scholar
  11. Pletscher, A., G. Bartholini, H. Brudere, W. P. Burkard, and K. F. Gey: Chlorinated arylalkylamines affecting the cerebral metabolism of 5-hydroxy-tryptamine. J. Pharmac. exp. Ther. 145, 344–350 (1964).Google Scholar
  12. Strada, S. J., E. Sanders-Bush, and F. Sulser: p-Chloroamphetamine. Temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine. Biochem. Pharmac. 19, 2621–2629 (1970).CrossRefGoogle Scholar
  13. Sulser, F., and E. Sanders-Bush: Effect of drugs on amines in the CNS. An. Rev. Pharmac. 11, 209–230 (1971).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1974

Authors and Affiliations

  • A. K. Pfeifer
    • 1
  1. 1.Institute for Experimental MedicineHungarian Academy of SciencesBudapestHungary

Personalised recommendations